Clinical Trials
3 trialsNCT02631746 2025-03-14
Nivolumab in Treating Patients With HTLV-Associated T-Cell Leukemia/Lymphoma
National Cancer Institute (NCI)
Phase 2 Completed
NCT00001156 2017-07-02
Assessment of Patients With Multiple Sclerosis (MS)
National Institutes of Health Clinical Center (CC)
Completed
NCT00001941 2012-08-20
Anti-Tac for Treatment of Leukemia
National Institutes of Health Clinical Center (CC)
Phase 1/2 Completed